Hemodynamic and Permeability Changes in Posterior Reversible Encephalopathy Syndrome Measured by Dynamic Susceptibility Perfusion-Weighted MR Imaging

References

1. ↵
   Kastrup O, Maschke M, Wanke I, Diener H. Posterior reversible encephalopathy syndrome due to severe hypercalcemia. J Neurol 2002;249:1563–1566

   CrossRefPubMedWeb of Science
2. ↵
   Sundgren P, Edvardson B, Holtas S. Serial investigarion of perfusion disturbances and vasogenic oedema in hypertensive encephalopathy by diffusion and perfusion weighted imaging. Neuroradiology 2002;44:299–304

   CrossRefPubMedWeb of Science
3. Arora A, Chowdhury D, Daga M, et al. Reversible posterior leukoencephalopathy syndrome: a report of 2 cases. Neurol India 2001;49:311–313

   PubMedWeb of Science
4. Eichler F, Wang P, Wityk R, et al. Diffuse metabolic abnormalities in reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol 2002;23:833–837

   Abstract/FREE Full Text
5. ↵
   Taylor M, Jackson A, Weller J. Dynamic susceptibility contrast enhanced MRI in reversible posterior leukoencephalopathy syndrome associated with haemolytic uraemic syndrome. Br J Radiol 2000;73:438–442

   Abstract
6. ↵
   Hinchley J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494–500

   CrossRefPubMedWeb of Science
7. ↵
   Provenzale JM, Petrella JR, Cruz LC Jr, et al. Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2000;22:1455–1461
8. ↵
   Engelter ST, Petrella JR, Alberts MJ, Provenzale JM. Assessment of cerebral microcirculation in a patient with hypertensive encephalopathy using MR perfusion imaging. AJR Am J Roentgenol 1999;173:1491–1493

   PubMed
9. ↵
   Weisskoff RM, Boxerman JL, Sorenson AG, et al. Simultaneous blood volume and permeability mapping using a single Gd-based contrast injection [Abstract]. In: Proceedings of the Society of Magnetic Resonance second meeting. San Francisco: Society of Magnetic Resonance;1994 :1:279
10. ↵
    Casey SO, Sampaio RC, Michel E, Truwit CL. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 2000;21:1199–1206

    Abstract/FREE Full Text
11. ↵
    Yu E, Roberts TPL, Mikulis DJ, Keller A. Physiologically specific imaging of posterior reversible encephalopathy syndrome [Abstract]. In: Proceedings of the American Society of Neuroradiology 42nd annual meeting, Seattle. Oak Brook, IL: American Society of Neuroradiology;2004 :18
12. ↵
    Bartynski WS, Lister J. Cyclosporin A/FK-506 neurotoxicity, preeclampsia/eclampsia and PRES syndrome: different names but similar systemic pathophysiology [abstract]. Proceedings of the American Society of Neuroradiology 42nd annual meeting, Seattle. Oak Brook, IL: American Society of Neuroradiology;2004 :86
13. ↵
    Gorniak RJT, Schwartz RB. Hypertensive encephalopathy: an investigation into the role of endothelial dysfunction [Abstract]. Proceedings of the American Society of Neuroradiology 42nd annual meeting, Seattle. Oak Brook, IL: American Society of Neuroradiology;2004 :82
14. ↵
    Gkogkas C, Klufas RA, Henderson GV, et al. Autonomic dysfuntion-induced hypertensive encephalopathy [Abstract]. Proceedings of the American Society of Neuroradiology 42nd annual meeting, Seattle. Oak Brook, IL: American Society of Neuroradiology;2004 :151
15. ↵
    Petrella JR, Provenzale JM. MR perfusion imaging of the brain: techniques and applications. AJR Am J Roentgenol 2000;175:207–219

    CrossRefPubMedWeb of Science
16. ↵
    Provenzale JM, Wang GR, Brenner T, et al. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 2002;178:711–716

    CrossRefPubMedWeb of Science
17. ↵
    Lin W, Lee JM, Lee YZ, et al. Temporal relationship between apparent diffusion coefficient and absolute measurements of cerebral blood flow in acute stroke patients. Stroke 2003;34:64–70

    Abstract/FREE Full Text
18. ↵
    Maeda M, Maley JE, Crosby DC, et al. Application of contrast agents in the evaluation of stroke: conventional MR and echo-planar MR imaging. J Magn Reson Imaging 1997;7:23–28

    CrossRefPubMed
19. ↵
    Pintacuda G, Otting G. Identification of protein surfaces by NMR measurements with a paramagnetic Gd(III) chelate. J Am Chem Soc 2002;124:372–373

    CrossRefPubMedWeb of Science
20. ↵
    An H, Lin W, Celik A, Lee YZ. Quantitative measurements of cerebral metabolic rate of oxygen utilization using MRI: a volunteer study. NMR Biomed 2001;14:441–447

    CrossRefPubMedWeb of Science
21. ↵
    21. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91–101

    CrossRefPubMedWeb of Science
22. ↵
    Kiessling F, Krix M, Heilman M, et al. Comparing dynamic parameters of tumor vascularization in nude mice revealed by magnetic resonance imaging and contrast-enhancing intermittent power Doppler sonography. Invest Radiol 2003;38:516–524

    CrossRefPubMedWeb of Science
23. ↵
    Østergaard L, Hochberg F, Rabinov J, et al. Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. J Neurosurg 1999;90:300–305

    PubMedWeb of Science